According to these results, we speculate that T cells that express IL-32 may have a contradictory role that promotes IFNγ expression in CD8+ T cells, which enhances the antitumor activity, and induces CD4+ T cells Foxp3 expression, which suppresses tumor immune response. The gene discussed is IFNG; the disease is neoplasm.